24 May 2013
Keywords: ucb, pharma, introduces, keppra, pregnancy, registry, launched
Article | 13 December 2004
UCB Pharma has launched a new surveillance study designed to monitor the result of pregnancies exposed to its anti-epileptic drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.